BRIEF published on 09/10/2025 at 08:40, 1 year ago Swixx BioPharma and Lundbeck Forge Multi-Regional CNS Partnership Emerging Markets Swixx BioPharma Healthcare Investments Lundbeck CNS Partnership
PRESS RELEASE published on 09/10/2025 at 08:35, 1 year ago HBM Portfolio Company Swixx BioPharma and Lundbeck Sign Multi-Regional CNS Partnership HBM Healthcare Investments announces partnership between Swixx BioPharma, Lundbeck for CNS therapies in South-East Europe, Turkey and Latin America Partnership HBM Healthcare Investments CNS Therapies Swixx BioPharma Lundbeck
BRIEF published on 09/01/2025 at 17:52, 1 year ago HBM Healthcare Investments AG Reports August 2025 Key Figures Performance Share Price NAV Swiss Exchange HBM Healthcare
PRESS RELEASE published on 09/01/2025 at 17:47, 1 year ago Key Figures 31.08.2025 HBM Healthcare Investments AG reports key financial figures for August 2025, with a NAV of 240.62 CHF and Total Net Assets of 1,610 million CHF. Share price increased by 4.0% HBM Healthcare Investments Financial Figures Share Price NAV August 2025
BRIEF published on 08/18/2025 at 17:52, 1 year ago HBM Healthcare Investments AG Reports August 2025 Key Figures Financial Performance Net Asset Value Share Price HBM Healthcare August 2025
PRESS RELEASE published on 08/18/2025 at 17:47, 1 year ago Key Figures 15.08.2025 HBM Healthcare Investments AG reports key figures for August 15, 2025, showing performance in CHF with NAV at 240.16 and share price at 175.60 Performance HBM Healthcare Investments AG Key Figures CHF August 15 2025
BRIEF published on 08/04/2025 at 17:51, 1 year 1 month ago HBM Healthcare Investments Declares July 2025 Key Figures Financial Performance Net Asset Value Share Price HBM Healthcare Investment Volatility
PRESS RELEASE published on 08/04/2025 at 17:46, 1 year 1 month ago Key Figures 31.07.2025 HBM Healthcare Investments AG reports key figures for July 31, 2025, with NAV at 232.47 CHF and total net assets of 1,557 million CHF. Performance percentages for MTD, FYTD, and CYTD also provided HBM Healthcare Investments AG Key Figures Total Net Assets Performance Percentages July 31 2025
BRIEF published on 07/18/2025 at 06:50, 1 year 1 month ago HBM Healthcare Investments Reports Q2 2025 Results Amid Currency Fluctuations Portfolio Performance Investment Strategy Quarterly Report Market Outlook Currency Fluctuations
PRESS RELEASE published on 07/18/2025 at 06:45, 1 year 1 month ago HBM Healthcare Investments publishes Quarterly Report for the period ending 30 June 2025 HBM Healthcare Investments reports 8.4% decline in NAV due to currency movements in Q1 2025/2026 fiscal year, with a CHF 140 million quarterly loss HBM Healthcare Investments Quarterly Report Financial Year Portfolio Currency Movements
Published on 09/14/2026 at 15:15, 11 minutes ago Mako Mining Announces a Non-Binding Letter of Intent to Enter a Gold Purchase Agreement with Sailfish Royalty to Lower its Cost of Capital and Facilitate Shareholder Returns and Accretive Acquisitions
Published on 09/14/2026 at 15:00, 26 minutes ago Vox Royalty Completes Acquisitions of White Dam, Kalman and Sylvania Australian Gold & Copper Royalties
Published on 09/14/2026 at 14:30, 56 minutes ago Goldcliff Finalizes Drill Plans for New East Breccia Gold-Silver Target at Kettle Valley
Published on 09/14/2026 at 14:00, 1 hour 26 minutes ago Revolve Completes Acquisition of 9.6 MW Operating Wind Project in the US
Published on 09/14/2026 at 14:00, 1 hour 26 minutes ago Kinross Encounters Gold and Copper in Recent Drill Holes with Gold Values up to 6 g/t, Kinross Drilling to Continue on Dixie Halo
Published on 09/14/2026 at 15:05, 20 minutes ago Avalara Named a Leader in IDC MarketScape: Worldwide E-Invoicing Compliance Solutions 2026
Published on 09/14/2026 at 14:35, 50 minutes ago Hisense Introduces RoamView, A Screen That Moves with the Way You Live
Published on 09/14/2026 at 14:35, 50 minutes ago Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.96 Million Tokens, and Total Crypto and Total Cash Holdings of $15.8 Billion
Published on 09/11/2026 at 07:00, 3 days 8 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 19 hours ago Availability of the 2026 Interim Financial Report
